Providence Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Providence Capital Advisors, LLC

$487 Million
Q3 2024

A detailed history of Providence Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 52,259 shares of BMY stock, worth $3.02 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

52,259

Previous 51,983 0.53%

Holding current value

$3.02 Million

Previous $2.16 Million 25.3%

% of portfolio

0.55%

Previous 0.48%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $10,946 - $14,283	276 Added 0.53%	52,259 $2.7 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $32,079 - $42,233	797 Added 1.56%	51,983 $2.16 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $623,835 - $707,308	13,002 Added 34.05%	51,186 $2.78 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $52,216 - $58,386	902 Added 2.42%	38,184 $2.22 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $39,882 - $44,283	626 Added 1.71%	37,282 $2.38 Million
Q1 2023 May 17, 2023	BUY	$65.71 - $74.53 $160 Million - $182 Million	2,438,440 Added 2385.95%	2,540,640 $176 Million
Q1 2023 May 17, 2023	SELL	$65.71 - $74.53 $165 Million - $187 Million	-2,503,984 Reduced 98.56%	36,656 $2.54 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $4.35 Million - $4.94 Million	66,218 Added 184.03%	102,200 $7.08 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $2,533 - $3,000	-37 Reduced 0.1%	35,982 $2.59 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $81 - $48,332	629 Added 1.78%	36,019 $2.56 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $98,400 - $108,372	1,355 Added 3.98%	35,390 $2.74 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $146,875 - $176,117	2,389 Added 7.55%	34,035 $2.49 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $78,407 - $91,404	1,462 Added 4.84%	31,646 $1.97 Million
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $126,742 - $148,462	2,142 Added 7.64%	30,184 $1.79 Million
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $160,594 - $174,887	2,594 Added 10.19%	28,042 $1.87 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $93,579 - $105,248	1,577 Added 6.61%	25,448 $1.61 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $235,059 - $266,365	4,071 Added 20.56%	23,871 $1.48 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $25,211 - $27,937	439 Added 2.27%	19,800 $1.19 Million
Q2 2020 Aug 04, 2020	BUY	$54.82 - $64.09 $1.06 Million - $1.23 Million	19,261 Added 19261.0%	19,361 $1.14 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $2.32 Million - $2.75 Million	-54,300 Reduced 99.82%	100 $5,000
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $352,498 - $389,786	7,900 Added 16.99%	54,400 $2.47 Million
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $225,600 - $269,000	5,000 Added 12.05%	46,500 $2.22 Million
Q4 2018 Feb 01, 2019	BUY	$48.76 - $63.23 $204,792 - $265,566	4,200 Added 11.26%	41,500 $2.16 Million
Q3 2018 Nov 08, 2018	BUY	$55.19 - $62.25 $2.04 Million - $2.3 Million	36,900 Added 9225.0%	37,300 $2.32 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $20,212 - $25,192	-400 Reduced 50.0%	400 $22,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $4,014 - $4,621	-67 Reduced 7.73%	800 $51,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $51,967 - $56,658	867	867 $53,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Bristol Myers Squibb CO Transaction History